Controlling infectious diseases
Every year several million people in the world's poorest countries die of AIDS, tuberculosis, malaria, sleeping sickness and other communicable diseases.
Stemming the spread of infectious diseases of this sort, is the sixth of the eight Millennium Development Goals. Progress over the last few years has been encouraging, but to finally stop diseases spreading, the international community will have to redouble its efforts.
The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) was launched in 2002 to improve cooperation between the various countries involved.
To date the GFATM has supported more than 1,000 programmes in 151 countries, at a cost of about 25 billion US dollars. This has made it possible to treat 4.2 million people living with HIV, and 9.7 tuberculosis sufferers. A total of 310 million impregnated mosquito nets have been distributed to prevent malaria.
Germany is the Global Fund’s fourth largest donor. Since the GFATM was founded, Germany has provided more than 1.5 billion US dollars. It currently contributes 200 million euros a year, and this sum has also been pledged for the period 2014 to 2016.
The German government is advocating an efficient, effective Global Fund, and has done much in recent years to make the work of the Fund more effective and more transparent.
Germany also supports the work of the GFATM through the German BACKUP (Building Alliances, Creating Knowledge and Updating Partners) Initiative.
The initiative is an innovative model encompassing multilateral and bilateral cooperation. Close cooperation with international organisations on the one hand and providing advisory services to state and civil society organisations in partner countries on the other facilitates the sharing of information and experience. Financial resources made available to the GFATM can thus be used more effectively.
Since 2002 the BACKUP Initiative has supported more than 500 measures implemented by partner organisations in 75 countries, focusing on three cross-cutting issues: strengthening civil society, gender equality and strengthening health systems.
Numerous interfaces exist between the field of sexual and reproductive health and efforts to combat HIV/AIDS. Firstly, there are many shared causes for impairment to sexual and reproductive health and high HIV rates, and secondly certain measures are helpful in both fields: young people need access to information, counselling and contraceptives, both to protect themselves against unplanned pregnancy and to prevent HIV infection. And avoiding teenage pregnancies helps both prevent the spread of HIV and improve the reproductive health of women.
Antenatal services offer a good opportunity to advise women on family planning matters and on HIV. Conversely, HIV services can and should be used to offer family planning services. In its development cooperation Germany is working to make better use of synergies in these areas.
Germany supports programmes in the field of social marketing in some 30 countries. In 2011 alone, Germany financed supplies of contraceptives in 16 developing countries for a total of 23.68 million US dollars. The contraceptives supplied would offer more than six million couples protection for a full year. Experience has shown that this is a promising approach.
In Kenya, Tanzania, Mozambique and Uganda, Germany is supporting programmes that aim to reduce the rate of mother-to-child transmission of HIV. The projects work within the framework of district health services in hospitals and health centres, where women are counselled when they attend antenatal appointments.
Germany is active in supporting the production of affordable drugs at local level. In Tanzania, Kenya and Ethiopia, for instance, Germany is promoting measures in the field of the local manufacture of generic drugs.
In Tanzania, measures are supporting the establishment of pharmaceutical teaching and development laboratories in cooperation with the University of Dar es Salaam and the church-affiliated St. Luke-Foundation. In Kenya, the BMZ is supporting the creation of an entire value chain from agricultural production to the manufacture of Artemisia-based antimalarial tablets. In Ethiopia, Germany is promoting the establishment of a laboratory that is to compare the effectiveness of generic drugs with the brand-name equivalent (bioequivalency testing).
Sector Strategy: German Development Policy in the Health Sector
Strategies 187 new window, PDF 321 KB, accessible 08/2009 | pdf | 321 KB | 22 P. | accessible
Sexual and Reproductive Health and Rights, and Population Dynamics
A BMZ Policy Paper new window, PDF 314 KB, accessible 08/2008 | pdf | 314 KB | 17 P. | accessible
to a Sustainable HIV Response
BMZ Strategy Paper new window, PDF 1.9 MB, accessible 06/2012 | pdf | 1.9 MB | 32 P. | accessible